There’s downward pressure from the late profitability peak Suominen’s Q1 marked a record high profitability despite raw materials and logist...
Group results quite in line with our expectations Detection Technology reported its Q2 results, whic...
Q2 results entailed visible cost synergies Bredband2’s Q2 results were solid.
God omsättning men svagare marginal Infrea redovisade en omsättningsökning på 27,8%, varav förvärvad tillväxt stod för 17% för Q2 2021 till ...
Redeye will likely raise its forecasts and Base case following a solid Q2 report, with EBIT beating ...
Redeye endorses Spago appointing Paul Hargreaves as Chief Development Officer as the company’s Tumor...
Talenom reported Q2 figures quite in line with expectations.
Talenom reported 30% y/y sales growth in Q2 21. Organic growth continued to recover and represented ...
We expect Inission to present a Q2 still hampered by component shortages and tough y/y comparables, ...
Redeye thinks the Q2 report from FlexQube was strong and shows that the company is solidly back on track after the pandemic.
Redeye endorses and is encouraged by IRRAS’ financing deal of some EUR 10m with EIB.
Redeye comments on the CEO change news this morning.
Redeye takes a positive stance to ADDvise’s acquisition of Medisuite.
Tufft jämförelseår Omsättningen steg 5% till 903 mkr (859), men var under vår förväntan om 1033 mkr.
ARR-tillväxt avslöjar operationell medvind Nettoomsättningen var 22 mkr vilket är i linje med våra e...
Redeye raises its valuation on Xbrane following the positive outcome of its phase III study Xplore.
Q2e EBITDA of USD 16m Based on the monthly production updates, we estimate Tethys’ Q2 working intere...
Medcap reported a better Q2 versus our estimates, attributable to a strong performance in the Medtec...
We expect Netcompany's solid performance continued in Q2, which may trigger a positive revision to its 2021 guidance, or at least a comment ...
Q2 drivet av förvärv och fortsatta Covid-19-tester För Q2 2021 ökade Addlife omsättningen med 82% ti...
Saniona beviljas ny särläkemedelsstatus för Tesomet av FDA för patienter med hypotalamisk fetma.
Kontraktstillverkaren Hanza levererade rekordhög lönsamhet under andra kvartalet trots att knappt en tredjedel av koncernen fortsatt påverka...
Redeye is growing somewhat more confident in the case as OXE Marine sees continued good progress in ...
Starkt resultat i Q2'21 Bergs Timber levererade omsättning på 826 mkr i Q2'21, motsvarande en tillvä...
Q1 started off rather slow Detection Technology will report its Q2 results next Tuesday on August 3rd.
Significant earnings growth also beyond the pandemic We believe that CTT is on track to recover from...
Service standing out in Q2 EBIT beat of 12% Q2 was characterized by a return to normalcy with organi...
Q2 results Market activity is improving, especially in ports.
Q2 EBITDA was SEK 146m, higher prices and volumes Q2 was a very strong quarter for Bergs Timber.
Key takes from the Q2’21 report Swedencare’s Q2’21 report was strong, although the company continues...
